Changi General Hospital clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

1. Notable

   Aldosterone-hybrid SteRoid for Guiding curablE Treatment of…Aldosterone-hybrid SteRoid for Guiding curablE Treatment of Primary Aldosteronism (TARGET-PA)

   Recruitment opened

   Changi General Hospital·Not applicable· NCT07297745· Registry history of NCT07297745 on ClinicalTrials.gov (opens the registry)

   Oct 2, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.